Insider Trading - PARMAR KUSH

Real time insider trading transaction history:

  1. Insiders must file a Form 4 covering their trades within two business days.
  2. Section 16 prohibits insiders from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period:
Insider Trading Transactions for PARMAR KUSH
Goto 0, 1, Next

Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2018-11-16
Sale
2018-11-20
5:05 pm
Homology Medicines Inc. FIXX PARMAR KUSH
Director
10% Owner
525,900 $20.2 $10,623,180 247,845
(Indirect)
View
2018-11-23
Sale
2018-11-27
6:09 pm
Homology Medicines Inc. FIXX PARMAR KUSH
Director
10% Owner
29,682 $20.04 $594,709 246,658
(Indirect)
View
2018-12-10
Sale
2018-12-12
8:10 pm
Homology Medicines Inc. FIXX PARMAR KUSH
Director
10% Owner
15,575 $26.01 $405,029 246,035
(Indirect)
View
2019-05-16
Sale
2019-05-20
4:24 pm
Homology Medicines Inc. FIXX PARMAR KUSH
Director
10% Owner
615,000 $21.47 $13,204,050 221,435
(Indirect)
View
2019-10-07
Purchase
2019-10-09
6:23 pm
Aprea Therapeutics Inc. APRE 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
DIEKMAN JOHN D
Schwab Andrew J.
PARMAR KUSH
10% Owner
333,333 $15 $4,999,995 333,333
(Indirect)
View
2019-10-29
Purchase
2019-10-31
6:03 pm
Cabaletta Bio Inc. CABA 5AM Ventures V L.P.
5AM Partners V LLC
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
PARMAR KUSH
ROCKLAGE SCOTT M
Schwab Andrew J.
10% Owner
454,545 $11 $4,999,995 454,545
(Indirect)
View
2020-05-19
Sale
2020-05-21
9:31 pm
Aprea Therapeutics Inc. APRE 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
DIEKMAN JOHN D
Schwab Andrew J.
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
PARMAR KUSH
10% Owner
255,000 $35.15 $8,963,250 423,905
(Indirect)
View
2020-06-11
Sale
2020-06-15
9:12 pm
Aprea Therapeutics Inc. APRE 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
DIEKMAN JOHN D
Schwab Andrew J.
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
PARMAR KUSH
10% Owner
245,000 $28.75 $7,044,412 414,105
(Indirect)
View
2020-06-16
Sale
2020-06-18
7:22 pm
Aprea Therapeutics Inc. APRE 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
DIEKMAN JOHN D
Schwab Andrew J.
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
PARMAR KUSH
10% Owner
140,000 $33.3 $4,662,000 313,497
(Indirect)
View
2020-06-30
Purchase
2020-07-02
4:17 pm
Akouos Inc. AKUS PARMAR KUSH
Director
10% Owner
294,117 $17 $4,999,989 1,094,101
(Indirect)
View
2020-10-05
Sale
2020-10-07
9:30 pm
Aprea Therapeutics Inc. APRE 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
DIEKMAN JOHN D
Schwab Andrew J.
PARMAR KUSH
ROCKLAGE SCOTT M
Former 10% holder
175,000 $25.3 $4,427,500 2,037,654
(Indirect)
View
2020-12-10
Sale
2020-12-14
5:58 pm
Cabaletta Bio Inc. CABA 5AM Ventures V L.P.
5AM Opportunities I (GP) LLC
5AM Opportunities I L.P.
5AM Partners V LLC
PARMAR KUSH
ROCKLAGE SCOTT M
Schwab Andrew J.
10% Owner
298,000 $14.75 $4,395,500 417,629
(Indirect)
View
2020-12-14
Sale
2020-12-16
7:25 pm
Homology Medicines Inc. FIXX PARMAR KUSH
Director
500,000 $12.25 $6,125,915 201,435
(Indirect)
View
2020-12-22
Sale
2020-12-28
9:37 pm
Homology Medicines Inc. FIXX PARMAR KUSH
Director
500,000 $12.82 $6,410,000 181,435
(Indirect)
View
2020-12-29
Sale
2020-12-31
9:32 pm
Akouos Inc. AKUS PARMAR KUSH
Director
10% Owner
470,000 $18 $8,460,000 982,453
(Indirect)
View
2021-01-08
Sale
2021-01-12
5:07 pm
Cabaletta Bio Inc. CABA 5AM Ventures V L.P.
5AM Opportunities I (GP) LLC
5AM Opportunities I L.P.
5AM Partners V LLC
PARMAR KUSH
ROCKLAGE SCOTT M
Schwab Andrew J.
10% Owner
387,000 $13 $5,031,000 369,688
(Indirect)
View
2021-02-05
Purchase
2021-02-09
5:15 pm
Vor Biopharma Inc. VOR PARMAR KUSH
Director
10% Owner
555,555 $18 $9,999,990 1,875,370
(Indirect
Direct)
View
2021-04-27
Purchase
2021-04-29
8:51 pm
IMPEL NEUROPHARMA INC IMPL 5AM Ventures V L.P.
5AM Partners V LLC
PARMAR KUSH
ROCKLAGE SCOTT M
Schwab Andrew J.
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
10% Owner
575,000 $15 $8,625,000 575,000
(Indirect)
View
2021-07-28
Purchase
2021-08-04
9:19 pm
Rallybio Corp RLYB PARMAR KUSH
Director
615,384 $13 $7,999,992 4,994,878
(Indirect
Direct)
View
2021-09-07
Sale
2021-09-09
5:34 pm
Cabaletta Bio Inc. CABA 5AM Ventures V L.P.
5AM Opportunities I (GP) LLC
5AM Opportunities I L.P.
5AM Partners V LLC
PARMAR KUSH
ROCKLAGE SCOTT M
Schwab Andrew J.
10% Owner
625,000 $9.7 $6,062,500 2,359,263
(Indirect)
View
2021-11-01
Sale
2021-11-03
4:38 pm
Cabaletta Bio Inc. CABA 5AM Ventures V L.P.
5AM Opportunities I (GP) LLC
5AM Opportunities I L.P.
5AM Partners V LLC
PARMAR KUSH
ROCKLAGE SCOTT M
Schwab Andrew J.
10% Owner
295,000 $13 $3,835,000 333,144
(Indirect)
View
2021-11-02
Purchase
2021-11-05
08:49 am
Entrada Therapeutics Inc. TRDA PARMAR KUSH
Director
10% Owner
250,000 $20 $5,000,000 1,132,357
(Indirect)
View
2021-11-16
Sale
2021-11-18
8:10 pm
Vor Biopharma Inc. VOR PARMAR KUSH
Director
10% Owner
330,706 $15.3 $5,059,802 1,766,634
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2018-04-02
Conversion
2018-04-04
4:24 pm
N/A
N/A
Homology Medicines Inc. FIXX PARMAR KUSH
Director
10% Owner
10,784,074 $0 6,722,076
(Indirect)
View
2018-04-02(A)
Conversion
2018-04-04
7:09 pm
N/A
N/A
Homology Medicines Inc. FIXX PARMAR KUSH
Director
10% Owner
5,392,037 $0 6,722,076
(Indirect)
View
2018-06-08
Option Award
2018-06-08
5:23 pm
N/A
2028-06-08
Audentes Therapeutics Inc. BOLD PARMAR KUSH
Director
10,000 $0 10,000
(Direct)
View
2018-06-19
Option Award
2018-06-21
6:39 pm
2019-06-19
2028-06-19
scPharmaceuticals Inc. SCPH PARMAR KUSH
Director
6,124 $0 6,124
(Direct)
View
2019-05-23
Option Award
2019-05-28
5:08 pm
N/A
2029-05-22
ARVINAS Inc ARVN PARMAR KUSH
Director
12,923 $0 12,923
(Direct)
View
2019-06-06
Option Award
2019-06-10
5:09 pm
N/A
2029-06-06
Homology Medicines Inc. FIXX PARMAR KUSH
Director
10% Owner
15,580 $0 15,580
(Direct)
View
2019-09-16
Other
2019-09-18
9:33 pm
N/A
N/A
ARVINAS Inc ARVN PARMAR KUSH
Director
3,475 $0 6,950
(Direct)
View
2019-09-24
Gift
2019-09-26
6:54 pm
N/A
N/A
ARVINAS Inc ARVN PARMAR KUSH
Director
1,700 $0 1,775
(Direct)
View
2019-10-07
Conversion
2019-10-09
6:23 pm
N/A
N/A
Aprea Therapeutics Inc. APRE 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
DIEKMAN JOHN D
Schwab Andrew J.
PARMAR KUSH
10% Owner
2,506,650 $0 333,333
(Indirect)
View
2019-10-29
Conversion
2019-10-31
6:03 pm
N/A
N/A
Cabaletta Bio Inc. CABA 5AM Ventures V L.P.
5AM Partners V LLC
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
PARMAR KUSH
ROCKLAGE SCOTT M
Schwab Andrew J.
10% Owner
8,036,804 $0 454,545
(Indirect)
View
2020-06-10
Option Award
2020-06-12
5:31 pm
N/A
2030-06-10
Homology Medicines Inc. FIXX PARMAR KUSH
Director
10% Owner
18,000 $0 18,000
(Direct)
View
2020-06-30
Conversion
2020-07-02
4:17 pm
N/A
N/A
Akouos Inc. AKUS PARMAR KUSH
Director
10% Owner
95,171,485 $0 1,094,101
(Indirect)
View
2020-10-16
Other
2020-10-20
8:42 pm
N/A
N/A
5:01 Acquisition Corp. FVAM PARMAR KUSH
CEO
10% Owner
90,000 $0 2,930,000
(Indirect)
View
2020-10-16
Other
2020-10-20
8:42 pm
N/A
N/A
5:01 Acquisition Corp. FVAM PARMAR KUSH
CEO
10% Owner
360,000 $10 2,930,000
(Indirect)
View
2020-11-12
Other
2020-11-12
5:53 pm
N/A
N/A
5:01 Acquisition Corp. FVAM PARMAR KUSH
CEO
10% Owner
5,126 $10 370,252
(Indirect)
View
2020-11-17
Other
2020-11-18
4:31 pm
N/A
N/A
5:01 Acquisition Corp. FVAM PARMAR KUSH
CEO
10% Owner
30,000 $0 2,180,000
(Indirect)
View
2020-11-30
Other
2020-12-01
5:42 pm
N/A
N/A
5:01 Acquisition Corp. FVAM PARMAR KUSH
CEO
10% Owner
235,932 $0 1,944,068
(Indirect)
View
2021-02-05
Option Award
2021-02-09
5:15 pm
N/A
2031-02-04
Vor Biopharma Inc. VOR PARMAR KUSH
Director
10% Owner
16,900 $0 1,875,370
(Direct)
View
2021-02-05
Conversion
2021-02-09
5:15 pm
N/A
N/A
Vor Biopharma Inc. VOR PARMAR KUSH
Director
10% Owner
88,184,384 $0 1,875,370
(Indirect)
View
2021-04-22
Other
2021-04-26
5:55 pm
N/A
2021-12-31
IMPEL NEUROPHARMA INC IMPL 5AM Ventures V L.P.
5AM Partners V LLC
PARMAR KUSH
ROCKLAGE SCOTT M
Schwab Andrew J.
10% Owner
1,359,799 $0 1,359,799
(Indirect)
View
2021-04-27
Conversion
2021-04-29
8:51 pm
N/A
N/A
IMPEL NEUROPHARMA INC IMPL 5AM Ventures V L.P.
5AM Partners V LLC
PARMAR KUSH
ROCKLAGE SCOTT M
Schwab Andrew J.
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
10% Owner
39,725,924 $0 575,000
(Indirect)
View
2021-04-27
Conversion
2021-04-29
8:51 pm
N/A
N/A
IMPEL NEUROPHARMA INC IMPL 5AM Ventures V L.P.
5AM Partners V LLC
PARMAR KUSH
ROCKLAGE SCOTT M
Schwab Andrew J.
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
10% Owner
101,457 $13.5 575,000
(Indirect)
View
2021-06-17
Option Award
2021-06-22
5:40 pm
N/A
2031-06-17
Homology Medicines Inc. FIXX PARMAR KUSH
Director
18,000 $0 18,000
(Direct)
View
2021-06-24
Option Award
2021-06-25
4:38 pm
N/A
2031-06-23
Akouos Inc. AKUS PARMAR KUSH
Director
10% Owner
16,000 $0 16,000
(Direct)
View
2021-07-28
Option Award
2021-08-04
9:19 pm
N/A
N/A
Rallybio Corp RLYB PARMAR KUSH
Director
13,440 $0 4,994,878
(Direct)
View
2021-07-28
Other
2021-08-04
9:19 pm
N/A
N/A
Rallybio Corp RLYB PARMAR KUSH
Director
26,341,690 $0 4,994,878
(Indirect)
View
2021-10-28
Option Award
2021-11-01
9:48 pm
N/A
2031-10-28
Entrada Therapeutics Inc. TRDA PARMAR KUSH
Director
10% Owner
23,552 $0 23,552
(Direct)
View
2021-11-02
Conversion
2021-11-05
08:49 am
N/A
N/A
Entrada Therapeutics Inc. TRDA PARMAR KUSH
Director
10% Owner
3,827,224 $0 1,132,357
(Indirect)
View
(A) Indicate amendment filing.
Goto 0, 1, Next